Column GROUP L P, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 126,478 shares at $11.29 ($1.4M) on 2019-10-18, disclosed to the SEC on 2019-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.62 | 6,818 | $72K | 5.0% |
| 2 | $10.62 | 6,818 | $72K | 5.0% |
| 3 | $11.29 | 34,721 | $392K | 27.1% |
| 4 | $11.29 | 34,721 | $392K | 27.1% |
| 5 | $11.94 | 43,400 | $518K | 35.8% |
| Total | $11.44 avg | 126,478 |
| $1.4M |
| 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |